N/KRAS-mutant AML LSCS originate from committed myelomonocytic progenitors and drive clinical resistance to venetoclax Meeting Abstract
| Authors: | Sango, J.; Carcamo, S.; Sirenko, M.; Maiti, A.; Mansour, H.; Ulukaya, G.; Tomalin, L.; Olivier, E.; Olszewska, M.; Demircioglu, D.; Landau, D.; Papaemmanuil, E.; DiNardo, C.; Hasson, D.; Konopleva, M.; Papapetrou, E. |
| Abstract Title: | N/KRAS-mutant AML LSCS originate from committed myelomonocytic progenitors and drive clinical resistance to venetoclax |
| Meeting Title: | 53rd Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH) |
| Journal Title: | Experimental Hematology |
| Volume: | 137 |
| Issue: | Suppl. |
| Meeting Dates: | 2024 Aug 29-Sep 1 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0301-472X |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2024-08-01 |
| Start Page: | 104569 |
| Language: | English |
| ACCESSION: | WOS:001325038400040 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.exphem.2024.104569 |
| Notes: | Meeting Abstract: 2012 -- Source: Wos |
